BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Phalipon A, Kaufmann M, Michetti P, Cavaillon JM, Huerre M, Sansonetti P, Kraehenbuhl JP. Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis. J Exp Med 1995;182:769-78. [PMID: 7544397 DOI: 10.1084/jem.182.3.769] [Cited by in Crossref: 141] [Cited by in F6Publishing: 125] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Hachani A, Biskri L, Rossi G, Marty A, Ménard R, Sansonetti P, Parsot C, Van Nhieu GT, Bernardini ML, Allaoui A. IpgB1 and IpgB2, two homologous effectors secreted via the Mxi-Spa type III secretion apparatus, cooperate to mediate polarized cell invasion and inflammatory potential of Shigella flexenri. Microbes Infect 2008;10:260-8. [PMID: 18316224 DOI: 10.1016/j.micinf.2007.11.011] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
2 Corthesy B, Kraehenbuhl J. Antibody-Mediated Protection of Mucosal Surfaces. In: Kraehenbuhl J, Neutra MR, editors. Defense of Mucosal Surfaces: Pathogenesis, Immunity and Vaccines. Berlin: Springer Berlin Heidelberg; 1999. pp. 93-111. [DOI: 10.1007/978-3-642-59951-4_6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 27] [Article Influence: 0.8] [Reference Citation Analysis]
3 Pal S, Theodor I, Peterson EM, de la Maza LM. Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chalamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge. Vaccine 1997;15:575-82. [DOI: 10.1016/s0264-410x(97)00206-5] [Cited by in Crossref: 74] [Cited by in F6Publishing: 45] [Article Influence: 3.0] [Reference Citation Analysis]
4 Ngo TT, Jogie‐brahim S, Narinesingh D. Affinity Chromatographic Purification of Antibodies. Analytical Letters 2007;40:2799-820. [DOI: 10.1080/00032710701653111] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
5 Isabel Fernandez M, Sansonetti PJ. Effector Molecules of Shigella Pathogenesis and Host Responses. In: Hecht GA, editor. Microbial Pathogenesis and the Intestinal Epithelial Cell. Washington: ASM Press; 2003. pp. 455-79. [DOI: 10.1128/9781555817848.ch25] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Fernandez MI, Pedron T, Tournebize R, Olivo-Marin JC, Sansonetti PJ, Phalipon A. Anti-inflammatory role for intracellular dimeric immunoglobulin a by neutralization of lipopolysaccharide in epithelial cells. Immunity 2003;18:739-49. [PMID: 12818156 DOI: 10.1016/s1074-7613(03)00122-5] [Cited by in Crossref: 119] [Cited by in F6Publishing: 43] [Article Influence: 6.3] [Reference Citation Analysis]
7 Cersini A, Martino MC, Martini I, Rossi G, Bernardini ML. Analysis of virulence and inflammatory potential of Shigella flexneri purine biosynthesis mutants. Infect Immun 2003;71:7002-13. [PMID: 14638790 DOI: 10.1128/IAI.71.12.7002-7013.2003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
8 Forbes SJ, Bumpus T, McCarthy EA, Corthésy B, Mantis NJ. Transient suppression of Shigella flexneri type 3 secretion by a protective O-antigen-specific monoclonal IgA. mBio 2011;2:e00042-11. [PMID: 21610121 DOI: 10.1128/mBio.00042-11] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
9 Crottet P, Peitsch MC, Servis C, Corthésy B. Covalent Homodimers of Murine Secretory Component Induced by Epitope Substitution Unravel the Capacity of the Polymeric Ig Receptor to Dimerize Noncovalently in the Absence of IgA Ligand. Journal of Biological Chemistry 1999;274:31445-55. [DOI: 10.1074/jbc.274.44.31445] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
10 Tanikawa T, Kurohane K, Imai Y. Production and characterization of IgA monoclonal antibody against ovalbumin. Hybridoma (Larchmt) 2007;26:328-32. [PMID: 17979550 DOI: 10.1089/hyb.2007.0514] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
11 Lindberg AA. Vaccination against enteric pathogens: from science to vaccine trials. Current Opinion in Microbiology 1998;1:116-24. [DOI: 10.1016/s1369-5274(98)80151-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Sansonetti PJ, Egile C, Wennerås C. Shigellosis: From Disease Symptoms to Molecular and Cellular Pathogenesis. Principles of Bacterial Pathogenesis. Elsevier; 2001. pp. 335-85. [DOI: 10.1016/b978-012304220-0/50009-1] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
13 Guan W, Chen J. Cell mediated immunity in Legionnaires’ disease. Vaccine 2011;29:6439-40. [DOI: 10.1016/j.vaccine.2011.07.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Bernardini ML, Arondel J, Martini I, Aidara A, Sansonetti PJ. Parameters underlying successful protection with live attenuated mutants in experimental shigellosis. Infect Immun 2001;69:1072-83. [PMID: 11160004 DOI: 10.1128/IAI.69.2.1072-1083.2001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Russell MW. Biological Functions of IgA. In: Kaetzel CS, editor. Mucosal Immune Defense: Immunoglobulin A. Boston: Springer US; 2007. pp. 144-72. [DOI: 10.1007/978-0-387-72232-0_6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
16 Kadaoui KA, Corthésy B. Secretory IgA mediates bacterial translocation to dendritic cells in mouse Peyer's patches with restriction to mucosal compartment. J Immunol 2007;179:7751-7. [PMID: 18025221 DOI: 10.4049/jimmunol.179.11.7751] [Cited by in Crossref: 113] [Cited by in F6Publishing: 104] [Article Influence: 8.1] [Reference Citation Analysis]
17 Adams MM, Allison GE, Verma NK. Type IV O antigen modification genes in the genome of Shigella flexneri NCTC 8296 The GenBank accession number for the sequence reported in this paper is AF288197. Microbiology 2001;147:851-60. [DOI: 10.1099/00221287-147-4-851] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.2] [Reference Citation Analysis]
18 Fisher ML, Castillo C, Mecsas J. Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP. Infect Immun 2007;75:429-42. [PMID: 17074849 DOI: 10.1128/IAI.01287-06] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
19 Mathias A, Longet S, Corthésy B. Agglutinating secretory IgA preserves intestinal epithelial cell integrity during apical infection by Shigella flexneri. Infect Immun 2013;81:3027-34. [PMID: 23753631 DOI: 10.1128/IAI.00303-13] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
20 Szijártó V, Hunyadi-Gulyás E, Emődy L, Pál T, Nagy G. Cross-protection provided by live Shigella mutants lacking major antigens. Int J Med Microbiol 2013;303:167-75. [PMID: 23567193 DOI: 10.1016/j.ijmm.2013.02.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
21 Liu G, Pilla G, Tang CM. Shigella host: Pathogen interactions: Keeping bacteria in the loop.Cell Microbiol. 2019;21:e13062. [PMID: 31134722 DOI: 10.1111/cmi.13062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
22 Sellge G, Magalhaes JG, Konradt C, Fritz JH, Salgado-Pabon W, Eberl G, Bandeira A, Di Santo JP, Sansonetti PJ, Phalipon A. Th17 cells are the dominant T cell subtype primed by Shigella flexneri mediating protective immunity. J Immunol 2010;184:2076-85. [PMID: 20089698 DOI: 10.4049/jimmunol.0900978] [Cited by in Crossref: 64] [Cited by in F6Publishing: 62] [Article Influence: 5.3] [Reference Citation Analysis]
23 Belotserkovsky I, Sansonetti PJ. Shigella and Enteroinvasive Escherichia Coli. Curr Top Microbiol Immunol 2018;416:1-26. [PMID: 30218158 DOI: 10.1007/82_2018_104] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
24 Al-Banna N, Raghupathy R, Albert MJ. Correlation of proinflammatory and anti-inflammatory cytokine levels with histopathological changes in an adult mouse lung model of Campylobacter jejuni infection. Clin Vaccine Immunol 2008;15:1780-7. [PMID: 18827187 DOI: 10.1128/CVI.00193-08] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
25 Corthésy B, Spertini F. Secretory Immunoglobulin A: from Mucosal Protection to Vaccine Development. Biological Chemistry 1999;380. [DOI: 10.1515/bc.1999.160] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
26 Jehl SP, Doling AM, Giddings KS, Phalipon A, Sansonetti PJ, Goldberg MB, Starnbach MN. Antigen-specific CD8(+) T cells fail to respond to Shigella flexneri. Infect Immun 2011;79:2021-30. [PMID: 21357720 DOI: 10.1128/IAI.00939-10] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
27 Phalipon A, Sansonetti PJ. Microbial-host interactions at mucosal sites. Host response to pathogenic bacteria at mucosal sites. Curr Top Microbiol Immunol. 1999;236:163-189. [PMID: 9893360 DOI: 10.1007/978-3-642-59951-4_9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
28 Mitra S, Barman S, Nag D, Sinha R, Saha DR, Koley H. Outer membrane vesicles of Shigella boydii type 4 induce passive immunity in neonatal mice. FEMS Immunol Med Microbiol 2012;66:240-50. [DOI: 10.1111/j.1574-695x.2012.01004.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
29 Phalipon A, Folgori A, Arondel J, Sgaramella G, Fortugno P, Cortese R, Sansonetti PJ, Felici F. Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics. Eur J Immunol. 1997;27:2620-2625. [PMID: 9368618 DOI: 10.1002/eji.1830271022] [Cited by in Crossref: 90] [Cited by in F6Publishing: 84] [Article Influence: 3.6] [Reference Citation Analysis]
30 Russell MW, Kilian M, Mantis NJ, Corthésy B. Biological Activities of IgA. Mucosal Immunology. Elsevier; 2015. pp. 429-54. [DOI: 10.1016/b978-0-12-415847-4.00021-5] [Cited by in Crossref: 11] [Article Influence: 1.6] [Reference Citation Analysis]
31 Philpott DJ, Yamaoka S, Israël A, Sansonetti PJ. Invasive Shigella flexneri activates NF-kappa B through a lipopolysaccharide-dependent innate intracellular response and leads to IL-8 expression in epithelial cells. J Immunol. 2000;165:903-914. [PMID: 10878365 DOI: 10.4049/jimmunol.165.2.903] [Cited by in Crossref: 194] [Cited by in F6Publishing: 180] [Article Influence: 8.8] [Reference Citation Analysis]
32 Bakema JE, van Egmond M. The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity. Mucosal Immunol 2011;4:612-24. [PMID: 21937986 DOI: 10.1038/mi.2011.36] [Cited by in Crossref: 95] [Cited by in F6Publishing: 85] [Article Influence: 8.6] [Reference Citation Analysis]
33 Phalipon A, Cardona A, Kraehenbuhl JP, Edelman L, Sansonetti PJ, Corthésy B. Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo. Immunity. 2002;17:107-115. [PMID: 12150896 DOI: 10.1016/S1074-7613(02)00341-2] [Cited by in Crossref: 302] [Cited by in F6Publishing: 138] [Article Influence: 15.1] [Reference Citation Analysis]
34 Marcotte H, Lavoie MC. Oral microbial ecology and the role of salivary immunoglobulin A. Microbiol Mol Biol Rev 1998;62:71-109. [PMID: 9529888 DOI: 10.1128/MMBR.62.1.71-109.1998] [Cited by in Crossref: 264] [Cited by in F6Publishing: 81] [Article Influence: 11.0] [Reference Citation Analysis]
35 Sansonetti PJ, Arondel J, Cantey JR, Prévost MC, Huerre M. Infection of rabbit Peyer's patches by Shigella flexneri: effect of adhesive or invasive bacterial phenotypes on follicle-associated epithelium. Infect Immun 1996;64:2752-64. [PMID: 8698505 DOI: 10.1128/iai.64.7.2752-2764.1996] [Cited by in Crossref: 132] [Cited by in F6Publishing: 53] [Article Influence: 5.1] [Reference Citation Analysis]
36 Corthésy B. Multi-faceted functions of secretory IgA at mucosal surfaces. Front Immunol 2013;4:185. [PMID: 23874333 DOI: 10.3389/fimmu.2013.00185] [Cited by in Crossref: 263] [Cited by in F6Publishing: 209] [Article Influence: 29.2] [Reference Citation Analysis]
37 Beatty WL, Méresse S, Gounon P, Davoust J, Mounier J, Sansonetti PJ, Gorvel JP. Trafficking of Shigella lipopolysaccharide in polarized intestinal epithelial cells. J Cell Biol 1999;145:689-98. [PMID: 10330399 DOI: 10.1083/jcb.145.4.689] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 1.8] [Reference Citation Analysis]
38 Jensen VB, Harty JT, Jones BD. Interactions of the Invasive Pathogens Salmonella typhimurium , Listeria monocytogenes , and Shigella flexneri with M Cells and Murine Peyer’s Patches. Infect Immun 1998;66:3758-66. [DOI: 10.1128/iai.66.8.3758-3766.1998] [Cited by in Crossref: 137] [Cited by in F6Publishing: 62] [Article Influence: 5.7] [Reference Citation Analysis]
39 Beatty WL, Sansonetti PJ. Role of lipopolysaccharide in signaling to subepithelial polymorphonuclear leukocytes. Infect Immun 1997;65:4395-404. [DOI: 10.1128/iai.65.11.4395-4404.1997] [Cited by in Crossref: 37] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
40 Fisher ML, Sun W, Curtiss R 3rd. The route less taken: pulmonary models of enteric Gram-negative infection. Pathog Dis 2014;70:99-109. [PMID: 24259516 DOI: 10.1111/2049-632X.12109] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
41 Sansonetti PJ, Phalipon A, Arondel J, Thirumalai K, Banerjee S, Akira S, Takeda K, Zychlinsky A. Caspase-1 Activation of IL-1β and IL-18 Are Essential for Shigella flexneri–Induced Inflammation. Immunity 2000;12:581-90. [DOI: 10.1016/s1074-7613(00)80209-5] [Cited by in Crossref: 292] [Cited by in F6Publishing: 140] [Article Influence: 13.3] [Reference Citation Analysis]
42 Suzuki T, Yoshikawa Y, Ashida H, Iwai H, Toyotome T, Matsui H, Sasakawa C. High Vaccine Efficacy against Shigellosis of Recombinant Noninvasive Shigella Mutant That Expresses Yersinia Invasin. J Immunol 2006;177:4709-17. [DOI: 10.4049/jimmunol.177.7.4709] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
43 Jennison AV, Roberts F, Verma NK. Construction of a multivalent vaccine strain of Shigella flexneri and evaluation of serotype-specific immunity. FEMS Immunology & Medical Microbiology 2006;46:444-51. [DOI: 10.1111/j.1574-695x.2006.00062.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
44 Raupach B, Zychlinsky A. Apoptosis and Enteric Bacterial Infections. In: Hecht GA, editor. Microbial Pathogenesis and the Intestinal Epithelial Cell. Washington: ASM Press; 2003. pp. 367-83. [DOI: 10.1128/9781555817848.ch20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
45 Singer M, Sansonetti PJ. IL-8 is a key chemokine regulating neutrophil recruitment in a new mouse model of Shigella-induced colitis. J Immunol 2004;173:4197-206. [PMID: 15356171 DOI: 10.4049/jimmunol.173.6.4197] [Cited by in Crossref: 122] [Cited by in F6Publishing: 115] [Article Influence: 6.8] [Reference Citation Analysis]
46 Mulard LA, Ughetto-monfrin J. First Synthesis of A Branched Pentasaccharide Representative of The Repeating Unit of The Shigella Flexneri Serotype 5A O -Antigen. Journal of Carbohydrate Chemistry 2000;19:193-220. [DOI: 10.1080/07328300008544074] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
47 Mulard LA, Costachel C, Sansonetti PJ. Synthesis of the Methyl Glycosides of a Di- and Two Trisaccharide Fragments Specific for the Shigella flexneri Serotype 2a O -Antigen. Journal of Carbohydrate Chemistry 2000;19:849-77. [DOI: 10.1080/07328300008544123] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.3] [Reference Citation Analysis]
48 Corthésy B. Role of secretory immunoglobulin A and secretory component in the protection of mucosal surfaces. Future Microbiol 2010;5:817-29. [PMID: 20441552 DOI: 10.2217/fmb.10.39] [Cited by in Crossref: 72] [Cited by in F6Publishing: 64] [Article Influence: 6.0] [Reference Citation Analysis]
49 Puhar A, Tronchère H, Payrastre B, Nhieu GT, Sansonetti PJ. A Shigella effector dampens inflammation by regulating epithelial release of danger signal ATP through production of the lipid mediator PtdIns5P. Immunity 2013;39:1121-31. [PMID: 24332032 DOI: 10.1016/j.immuni.2013.11.013] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 7.0] [Reference Citation Analysis]
50 Londono P, Gao XM, Bowe F, McPheat WL, Booth G, Dougan G. Evaluation of the intranasal challenge route in mice as a mucosal model for Candida albicans infection. Microbiology (Reading) 1998;144 ( Pt 8):2291-8. [PMID: 9720052 DOI: 10.1099/00221287-144-8-2291] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
51 Spencer J, Boursier L, Edgeworth JD. IgA Plasma Cell Development. In: Kaetzel CS, editor. Mucosal Immune Defense: Immunoglobulin A. Boston: Springer US; 2007. pp. 25-42. [DOI: 10.1007/978-0-387-72232-0_2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
52 Russell MW, Kilian M. Biological Activities of IgA. Mucosal Immunology. Elsevier; 2005. pp. 267-89. [DOI: 10.1016/b978-012491543-5/50018-8] [Cited by in Crossref: 16] [Article Influence: 0.9] [Reference Citation Analysis]
53 Nag D, Koley H, Sinha R, Mukherjee P, Sarkar C, Withey JH, Gachhui R. Immunization of Mice with a Live Transconjugant Shigella Hybrid Strain Induced Th1 and Th17 Cell-Mediated Immune Responses and Confirmed Passive Protection Against Heterologous Shigellae. Scand J Immunol 2016;83:92-101. [PMID: 26478541 DOI: 10.1111/sji.12394] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
54 Sun Q, Knirel YA, Lan R, Wang J, Senchenkova SN, Jin D, Shashkov AS, Xia S, Perepelov AV, Chen Q, Wang Y, Wang H, Xu J. A novel plasmid-encoded serotype conversion mechanism through addition of phosphoethanolamine to the O-antigen of Shigella flexneri. PLoS One 2012;7:e46095. [PMID: 23049947 DOI: 10.1371/journal.pone.0046095] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
55 Pitisuttithum P, Islam D, Chamnanchanunt S, Ruamsap N, Khantapura P, Kaewkungwal J, Kittitrakul C, Luvira V, Dhitavat J, Venkatesan MM, Mason CJ, Bodhidatta L. Clinical Trial of an Oral Live Shigella sonnei Vaccine Candidate, WRSS1, in Thai Adults. Clin Vaccine Immunol 2016;23:564-75. [PMID: 27146000 DOI: 10.1128/CVI.00665-15] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
56 Iankov ID, Petrov DP, Mladenov IV, Haralambieva IH, Ivanova R, Sechanova L, Mitov IG. Monoclonal antibodies of IgA isotype specific for lipopolysaccharide of Salmonella enteritidis: production, purification, characterization and application as serotyping reagents. FEMS Microbiol Lett 2001;196:215-21. [PMID: 11267782 DOI: 10.1111/j.1574-6968.2001.tb10567.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
57 Ashida H, Ogawa M, Mimuro H, Sasakawa C. Shigella Infection of Intestinal Epithelium and Circumvention of the Host Innate Defense System. In: Sasakawa C, editor. Molecular Mechanisms of Bacterial Infection via the Gut. Berlin: Springer Berlin Heidelberg; 2009. pp. 231-55. [DOI: 10.1007/978-3-642-01846-6_8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
58 Bakema JE, van Egmond M. Immunoglobulin A: A next generation of therapeutic antibodies? MAbs 2011;3:352-61. [PMID: 21691145 DOI: 10.4161/mabs.3.4.16092] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 4.6] [Reference Citation Analysis]
59 Casadevall A. Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle. Infect Immun 2003;71:4225-8. [PMID: 12874297 DOI: 10.1128/IAI.71.8.4225-4228.2003] [Cited by in Crossref: 76] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
60 Wright K, Guerreiro C, Laurent I, Baleux F, Mulard LA. Preparation of synthetic glycoconjugates as potential vaccines against Shigella flexneri serotype 2a disease. Org Biomol Chem 2004;2:1518-27. [DOI: 10.1039/b400986j] [Cited by in Crossref: 29] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
61 Mantis NJ, Forbes SJ. Secretory IgA: arresting microbial pathogens at epithelial borders. Immunol Invest. 2010;39:383-406. [PMID: 20450284 DOI: 10.3109/08820131003622635] [Cited by in Crossref: 100] [Cited by in F6Publishing: 91] [Article Influence: 8.3] [Reference Citation Analysis]
62 Mansfield JM, Way SS, Borczuk AC, Goldberg MB. Adaptive Immune Response to Shigella flexneri 2a cydC in Immunocompetent Mice and Mice Lacking Immunoglobulin A. Infect Immun 1999;67:2001-4. [DOI: 10.1128/iai.67.4.2001-2004.1999] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
63 Loy AL, Allison G, Arias CF, Verma NK. Immune response to rotavirus VP4 expressed in an attenuated strain of Shigella flexneri. FEMS Immunol Med Microbiol 1999;25:283-8. [PMID: 10459583 DOI: 10.1111/j.1574-695X.1999.tb01353.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
64 Fullner KJ, Boucher JC, Hanes MA, Haines GK 3rd, Meehan BM, Walchle C, Sansonetti PJ, Mekalanos JJ. The contribution of accessory toxins of Vibrio cholerae O1 El Tor to the proinflammatory response in a murine pulmonary cholera model. J Exp Med 2002;195:1455-62. [PMID: 12045243 DOI: 10.1084/jem.20020318] [Cited by in Crossref: 97] [Cited by in F6Publishing: 90] [Article Influence: 4.9] [Reference Citation Analysis]
65 Duc M, Johansen FE, Corthésy B. Antigen binding to secretory immunoglobulin A results in decreased sensitivity to intestinal proteases and increased binding to cellular Fc receptors. J Biol Chem 2010;285:953-60. [PMID: 19910466 DOI: 10.1074/jbc.M109.059220] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
66 Boullier S, Tanguy M, Kadaoui KA, Caubet C, Sansonetti P, Corthésy B, Phalipon A. Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits. J Immunol 2009;183:5879-85. [PMID: 19828639 DOI: 10.4049/jimmunol.0901838] [Cited by in Crossref: 101] [Cited by in F6Publishing: 99] [Article Influence: 7.8] [Reference Citation Analysis]
67 Howe SE, Konjufca VH. Per-oral immunization with antigen-conjugated nanoparticles followed by sub-cutaneous boosting immunization induces long-lasting mucosal and systemic antibody responses in mice. PLoS One 2015;10:e0118067. [PMID: 25710518 DOI: 10.1371/journal.pone.0118067] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
68 Heine SJ, Diaz-McNair J, Andar AU, Drachenberg CB, van de Verg L, Walker R, Picking WL, Pasetti MF. Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes. J Immunol 2014;192:1630-40. [PMID: 24453241 DOI: 10.4049/jimmunol.1302743] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
69 Corthésy B, Benureau Y, Perrier C, Fourgeux C, Parez N, Greenberg H, Schwartz-Cornil I. Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion. J Virol 2006;80:10692-9. [PMID: 16956954 DOI: 10.1128/JVI.00927-06] [Cited by in Crossref: 93] [Cited by in F6Publishing: 46] [Article Influence: 5.8] [Reference Citation Analysis]
70 Wells JM, Brummer RJ, Derrien M, MacDonald TT, Troost F, Cani PD, Theodorou V, Dekker J, Méheust A, de Vos WM, Mercenier A, Nauta A, Garcia-Rodenas CL. Homeostasis of the gut barrier and potential biomarkers. Am J Physiol Gastrointest Liver Physiol 2017;312:G171-93. [PMID: 27908847 DOI: 10.1152/ajpgi.00048.2015] [Cited by in Crossref: 188] [Cited by in F6Publishing: 177] [Article Influence: 31.3] [Reference Citation Analysis]
71 Jedani KE, Stroeher U, Manning PA. Distribution of IS1358 and linkage to rfb-related genes in Vibrio anguillarum The GenBank accession numbers for the IS1358 sequences are U93587–U93597. Microbiology 2000;146:323-31. [DOI: 10.1099/00221287-146-2-323] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
72 Rochereau N, Roblin X, Michaud E, Gayet R, Chanut B, Jospin F, Corthésy B, Paul S. NOD2 deficiency increases retrograde transport of secretory IgA complexes in Crohn's disease. Nat Commun 2021;12:261. [PMID: 33431850 DOI: 10.1038/s41467-020-20348-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
73 Rasolofo-Razanamparany V, Cassel-Beraud AM, Roux J, Sansonetti PJ, Phalipon A. Predominance of serotype-specific mucosal antibody response in Shigella flexneri-infected humans living in an area of endemicity. Infect Immun 2001;69:5230-4. [PMID: 11500390 DOI: 10.1128/IAI.69.9.5230-5234.2001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
74 Phalipon A, Costachel C, Grandjean C, Thuizat A, Guerreiro C, Tanguy M, Nato F, Vulliez-Le Normand B, Bélot F, Wright K, Marcel-Peyre V, Sansonetti PJ, Mulard LA. Characterization of functional oligosaccharide mimics of the Shigella flexneri serotype 2a O-antigen: implications for the development of a chemically defined glycoconjugate vaccine. J Immunol 2006;176:1686-94. [PMID: 16424198 DOI: 10.4049/jimmunol.176.3.1686] [Cited by in Crossref: 89] [Cited by in F6Publishing: 78] [Article Influence: 5.6] [Reference Citation Analysis]
75 Forestier C, Moreno E, Méresse S, Phalipon A, Olive D, Sansonetti P, Gorvel JP. Interaction of Brucella abortus lipopolysaccharide with major histocompatibility complex class II molecules in B lymphocytes. Infect Immun 1999;67:4048-54. [PMID: 10417173 DOI: 10.1128/IAI.67.8.4048-4054.1999] [Cited by in Crossref: 30] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
76 Toapanta FR, Simon JK, Barry EM, Pasetti MF, Levine MM, Kotloff KL, Sztein MB. Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans. Front Immunol 2014;5:374. [PMID: 25191323 DOI: 10.3389/fimmu.2014.00374] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
77 Al-banna NA, Junaid TA, Mathew TC, Raghupathy R, Albert MJ. Histopathological and ultrastructural studies of a mouse lung model of Campylobacter jejuni infection. Journal of Medical Microbiology 2008;57:210-7. [DOI: 10.1099/jmm.0.47624-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
78 Corthésy B, Monnerat J, Lötscher M, Vonarburg C, Schaub A, Bioley G. Oral Passive Immunization With Plasma-Derived Polyreactive Secretory-Like IgA/M Partially Protects Mice Against Experimental Salmonellosis. Front Immunol 2018;9:2970. [PMID: 30619327 DOI: 10.3389/fimmu.2018.02970] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
79 Phalipon A, Sansonetti PJ. Shigella’ s ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival? Immunol Cell Biol 2007;85:119-29. [DOI: 10.1038/sj.icb7100025] [Cited by in Crossref: 161] [Cited by in F6Publishing: 142] [Article Influence: 10.7] [Reference Citation Analysis]
80 Fernandez MI, Thuizat A, Pedron T, Neutra M, Phalipon A, Sansonetti PJ. A newborn mouse model for the study of intestinal pathogenesis of shigellosis. Cell Microbiol 2003;5:481-91. [DOI: 10.1046/j.1462-5822.2003.00295.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 2.8] [Reference Citation Analysis]
81 Casadevall A. Antibody-mediated protection against intracellular pathogens. Trends Microbiol 1998;6:102-7. [PMID: 9582935 DOI: 10.1016/s0966-842x(98)01208-6] [Cited by in Crossref: 90] [Cited by in F6Publishing: 48] [Article Influence: 3.8] [Reference Citation Analysis]
82 Sierocki R, Jneid B, Orsini Delgado ML, Plaisance M, Maillère B, Nozach H, Simon S. An antibody targeting type III secretion system induces broad protection against Salmonella and Shigella infections. PLoS Negl Trop Dis 2021;15:e0009231. [PMID: 33711056 DOI: 10.1371/journal.pntd.0009231] [Reference Citation Analysis]
83 Day CJ, Tran EN, Semchenko EA, Tram G, Hartley-Tassell LE, Ng PS, King RM, Ulanovsky R, McAtamney S, Apicella MA, Tiralongo J, Morona R, Korolik V, Jennings MP. Glycan:glycan interactions: High affinity biomolecular interactions that can mediate binding of pathogenic bacteria to host cells. Proc Natl Acad Sci U S A 2015;112:E7266-75. [PMID: 26676578 DOI: 10.1073/pnas.1421082112] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 9.0] [Reference Citation Analysis]
84 Way SS, Borczuk AC, Goldberg MB. Thymic independence of adaptive immunity to the intracellular pathogen Shigella flexneri serotype 2a. Infect Immun 1999;67:3970-9. [PMID: 10417163 DOI: 10.1128/IAI.67.8.3970-3979.1999] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
85 Casadevall A, Pirofski L. A Reappraisal of Humoral Immunity Based on Mechanisms of Antibody‐Mediated Protection Against Intracellular Pathogens. Elsevier; 2006. pp. 1-44. [DOI: 10.1016/s0065-2776(06)91001-3] [Cited by in Crossref: 114] [Cited by in F6Publishing: 62] [Article Influence: 7.1] [Reference Citation Analysis]
86 Iankov ID, Petrov DP, Mladenov IV, Haralambieva IH, Kalev OK, Balabanova MS, Mitov IG. Protective efficacy of IgA monoclonal antibodies to O and H antigens in a mouse model of intranasal challenge with Salmonella enterica serotype Enteritidis. Microbes and Infection 2004;6:901-10. [DOI: 10.1016/j.micinf.2004.05.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
87 Jennison AV, Verma NK. Shigella flexneri infection: pathogenesis and vaccine development. FEMS Microbiol Rev. 2004;28:43-58. [PMID: 14975529 DOI: 10.1016/j.femsre.2003.07.002] [Cited by in Crossref: 144] [Cited by in F6Publishing: 131] [Article Influence: 8.0] [Reference Citation Analysis]
88 Barzu S, Fontaine A, Sansonetti P, Phalipon A. Induction of a local anti-IpaC antibody response in mice by use of a Shigella flexneri 2a vaccine candidate: implications for use of IpaC as a protein carrier. Infect Immun 1996;64:1190-6. [DOI: 10.1128/iai.64.4.1190-1196.1996] [Cited by in Crossref: 31] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
89 Launay P, Grossetête B, Arcos-Fajardo M, Gaudin E, Torres SP, Beaudoin L, Patey-Mariaud de Serre N, Lehuen A, Monteiro RC. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice. J Exp Med 2000;191:1999-2009. [PMID: 10839814 DOI: 10.1084/jem.191.11.1999] [Cited by in Crossref: 160] [Cited by in F6Publishing: 145] [Article Influence: 7.3] [Reference Citation Analysis]
90 Turbyfill KR, Mertz JA, Mallett CP, Oaks EV. Identification of epitope and surface-exposed domains of Shigella flexneri invasion plasmid antigen D (IpaD). Infect Immun 1998;66:1999-2006. [PMID: 9573082 DOI: 10.1128/IAI.66.5.1999-2006.1998] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
91 Sansonetti P, Phalipon A. Shigellosis: from molecular pathogenesis of infection to protective immunity and vaccine development. Res Immunol 1996;147:595-602. [PMID: 9127893 DOI: 10.1016/s0923-2494(97)85227-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
92 Shim D, Suzuki T, Chang S, Park S, Sansonetti PJ, Sasakawa C, Kweon M. New Animal Model of Shigellosis in the Guinea Pig: Its Usefulness for Protective Efficacy Studies. J Immunol 2007;178:2476-82. [DOI: 10.4049/jimmunol.178.4.2476] [Cited by in Crossref: 73] [Cited by in F6Publishing: 64] [Article Influence: 4.9] [Reference Citation Analysis]
93 Martino MC, Rossi G, Tattoli I, Martini I, Chiavolini D, Cortese G, Pozzi G, Bernardini ML. Intravenous infection of virulent shigellae causes fulminant hepatitis in mice: A murine systemic model for shigellosis. Cellular Microbiology 2005;7:115-27. [DOI: 10.1111/j.1462-5822.2004.00441.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
94 Schroeder GN, Hilbi H. Molecular pathogenesis of Shigella spp.: controlling host cell signaling, invasion, and death by type III secretion. Clin Microbiol Rev 2008;21:134-56. [PMID: 18202440 DOI: 10.1128/CMR.00032-07] [Cited by in Crossref: 365] [Cited by in F6Publishing: 197] [Article Influence: 26.1] [Reference Citation Analysis]
95 Arondel J, Singer M, Matsukawa A, Zychlinsky A, Sansonetti PJ. Increased interleukin-1 (IL-1) and imbalance between IL-1 and IL-1 receptor antagonist during acute inflammation in experimental Shigellosis. Infect Immun 1999;67:6056-66. [PMID: 10531267 DOI: 10.1128/IAI.67.11.6056-6066.1999] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
96 Haines GK 3rd, Sayed BA, Rohrer MS, Olivier V, Satchell KJ. Role of toll-like receptor 4 in the proinflammatory response to Vibrio cholerae O1 El tor strains deficient in production of cholera toxin and accessory toxins. Infect Immun 2005;73:6157-64. [PMID: 16113340 DOI: 10.1128/IAI.73.9.6157-6164.2005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
97 Jneid B, Rouaix A, Féraudet-Tarisse C, Simon S. SipD and IpaD induce a cross-protection against Shigella and Salmonella infections. PLoS Negl Trop Dis 2020;14:e0008326. [PMID: 32463817 DOI: 10.1371/journal.pntd.0008326] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
98 Ingersoll M, Groisman EA, Zychlinsky A. Pathogenicity Islands of Shigella. In: Hacker J, Kaper JB, editors. Pathogenicity Islands and the Evolution of Pathogenic Microbes. Berlin: Springer Berlin Heidelberg; 2002. pp. 49-65. [DOI: 10.1007/978-3-642-56031-6_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
99 Kennel-De March A, Prin-Mathieu C, Kohler CH, Kolopp-Sarda MN, Faure GC, Béné MV. Back-pack mice as a model of renal mesangial IgA dimers deposition. Int J Immunopathol Pharmacol 2005;18:701-8. [PMID: 16388718 DOI: 10.1177/039463200501800412] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
100 Macpherson AJ, Hunziker L, McCoy K, Lamarre A. IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms. Microbes Infect. 2001;3:1021-1035. [PMID: 11580989 DOI: 10.1016/S1286-4579(01)01460-5] [Cited by in Crossref: 177] [Cited by in F6Publishing: 55] [Article Influence: 8.4] [Reference Citation Analysis]
101 Turbyfill KR, Hartman AB, Oaks EV. Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine. Infect Immun. 2000;68:6624-6632. [DOI: 10.1128/IAI.68.12.6624-6632.2000] [Cited by in Crossref: 59] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
102 Mulard LA, Ughetto-monfrin J. Synthesis of a Tri- and Tetrasaccharide Fragment Specific for the Shigella flexneri Serotype 5a O -Antigen. A Reinvestigation. Journal of Carbohydrate Chemistry 1999;18:721-53. [DOI: 10.1080/07328309908544033] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
103 Chamekh M, Phalipon A, Quertainmont R, Salmon I, Sansonetti P, Allaoui A. Delivery of biologically active anti-inflammatory cytokines IL-10 and IL-1ra in vivo by the Shigella type III secretion apparatus. J Immunol 2008;180:4292-8. [PMID: 18322242 DOI: 10.4049/jimmunol.180.6.4292] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
104 Brunner K, Samassa F, Sansonetti PJ, Phalipon A. Shigella-mediated immunosuppression in the human gut: subversion extends from innate to adaptive immune responses. Hum Vaccin Immunother 2019;15:1317-25. [PMID: 30964713 DOI: 10.1080/21645515.2019.1594132] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
105 Uren TK, Wijburg OL, Simmons C, Johansen FE, Brandtzaeg P, Strugnell RA. Vaccine-induced protection against gastrointestinal bacterial infections in the absence of secretory antibodies. Eur J Immunol. 2005;35:180-188. [PMID: 15593123 DOI: 10.1002/eji.200425492] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 3.4] [Reference Citation Analysis]
106 Vepachedu R, Karim Z, Patel O, Goplen N, Alam R. Unc119 protects from Shigella infection by inhibiting the Abl family kinases. PLoS One 2009;4:e5211. [PMID: 19381274 DOI: 10.1371/journal.pone.0005211] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
107 Reljic R, Williams A, Ivanyi J. Mucosal immunotherapy of tuberculosis: is there a value in passive IgA? Tuberculosis (Edinb) 2006;86:179-90. [PMID: 16510311 DOI: 10.1016/j.tube.2006.01.011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
108 Raqib R, Qadri F, Sarker P, Mia SMS, Sansonnetti PJ, Albert MJ, Andersson J. Delayed and Reduced Adaptive Humoral Immune Responses in Children with Shigellosis Compared with in Adults: Reduced Specific Immunity in Children with Shigellosis. Scandinavian Journal of Immunology 2002;55:414-23. [DOI: 10.1046/j.1365-3083.2002.01079.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.5] [Reference Citation Analysis]
109 Sood S, Rishi P, Dhawan V, Sharma S, Ganguly NK. Protection mediated by antibodies to iron-regulated outer-membrane proteins of S. typhi in a mouse peritonitis model. Mol Cell Biochem 2005;273:69-78. [DOI: 10.1007/s11010-005-7756-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
110 Joller N, Spörri R, Hilbi H, Oxenius A. Induction and protective role of antibodies inLegionella pneumophila infection. Eur J Immunol 2007;37:3414-23. [DOI: 10.1002/eji.200737591] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
111 Rochereau N, Drocourt D, Perouzel E, Pavot V, Redelinghuys P, Brown GD, Tiraby G, Roblin X, Verrier B, Genin C, Corthésy B, Paul S. Dectin-1 is essential for reverse transcytosis of glycosylated SIgA-antigen complexes by intestinal M cells. PLoS Biol 2013;11:e1001658. [PMID: 24068891 DOI: 10.1371/journal.pbio.1001658] [Cited by in Crossref: 102] [Cited by in F6Publishing: 89] [Article Influence: 11.3] [Reference Citation Analysis]
112 Mathias A, Corthésy B. Recognition of gram-positive intestinal bacteria by hybridoma- and colostrum-derived secretory immunoglobulin A is mediated by carbohydrates. J Biol Chem 2011;286:17239-47. [PMID: 21454510 DOI: 10.1074/jbc.M110.209015] [Cited by in Crossref: 68] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
113 Clément MJ, Fortuné A, Phalipon A, Marcel-Peyre V, Simenel C, Imberty A, Delepierre M, Mulard LA. Toward a better understanding of the basis of the molecular mimicry of polysaccharide antigens by peptides: the example of Shigella flexneri 5a. J Biol Chem 2006;281:2317-32. [PMID: 16251186 DOI: 10.1074/jbc.M510172200] [Cited by in Crossref: 31] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
114 Clément M, Imberty A, Phalipon A, Pérez S, Simenel C, Mulard LA, Delepierre M. Conformational Studies of the O-specific Polysaccharide of Shigella flexneri 5a and of Four Related Synthetic Pentasaccharide Fragments Using NMR and Molecular Modeling. Journal of Biological Chemistry 2003;278:47928-36. [DOI: 10.1074/jbc.m308259200] [Cited by in Crossref: 30] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
115 Imai Y, Ishikawa T, Tanikawa T, Nakagami H, Maekawa T, Kurohane K. Production of IgA monoclonal antibody against Shiga toxin binding subunits employing nasal-associated lymphoid tissue. J Immunol Methods 2005;302:125-35. [PMID: 15992815 DOI: 10.1016/j.jim.2005.05.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
116 Mikulic J, Bioley G, Corthésy B. SIgA–Shigella Immune Complexes Interact with Dectin-1 and SIGNR3 to Differentially Regulate Mouse Peyer's Patch and Mesenteric Lymph Node Dendritic Cell's Responsiveness. Journal of Molecular Biology 2017;429:2387-400. [DOI: 10.1016/j.jmb.2017.05.024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
117 Ohya K, Handa Y, Ogawa M, Suzuki M, Sasakawa C. IpgB1 is a novel Shigella effector protein involved in bacterial invasion of host cells. Its activity to promote membrane ruffling via Rac1 and Cdc42 activation. J Biol Chem 2005;280:24022-34. [PMID: 15849186 DOI: 10.1074/jbc.M502509200] [Cited by in Crossref: 83] [Cited by in F6Publishing: 45] [Article Influence: 4.9] [Reference Citation Analysis]
118 Costachel C, Sansonetti PJ, Mulard LA. Linear Synthesis of the Methyl Glycosides of Tetra- and Pentasaccharide Fragments Specific for the Shigella flexneri Serotype 2a O -Antigen. Journal of Carbohydrate Chemistry 2000;19:1131-50. [DOI: 10.1080/07328300008544139] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
119 Le-Barillec K, Magalhaes JG, Corcuff E, Thuizat A, Sansonetti PJ, Phalipon A, Di Santo JP. Roles for T and NK cells in the innate immune response to Shigella flexneri. J Immunol 2005;175:1735-40. [PMID: 16034114 DOI: 10.4049/jimmunol.175.3.1735] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 3.4] [Reference Citation Analysis]
120 Fassina G, Ruvo M, Palombo G, Verdoliva A, Marino M. Novel ligands for the affinity-chromatographic purification of antibodies. Journal of Biochemical and Biophysical Methods 2001;49:481-90. [DOI: 10.1016/s0165-022x(01)00215-9] [Cited by in Crossref: 102] [Cited by in F6Publishing: 6] [Article Influence: 4.9] [Reference Citation Analysis]
121 Philpott DJ, Edgeworth JD, Sansonetti PJ. The pathogenesis of Shigella flexneri infection: lessons from in vitro and in vivo studies. Philos Trans R Soc Lond B Biol Sci 2000;355:575-86. [PMID: 10874731 DOI: 10.1098/rstb.2000.0599] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 3.0] [Reference Citation Analysis]
122 Adhikari P, Allison G, Whittle B, Verma NK. Serotype 1a O-Antigen Modification: Molecular Characterization of the Genes Involved and Their Novel Organization in the Shigella flexneri Chromosome. J Bacteriol 1999;181:4711-8. [DOI: 10.1128/jb.181.15.4711-4718.1999] [Cited by in Crossref: 39] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
123 Chen JH, Hsu WB, Chiou CS, Chen CM. Conversion of Shigella flexneri serotype 2a to serotype Y in a shigellosis patient due to a single amino acid substitution in the protein product of the bacterial glucosyltransferase gtrII gene. FEMS Microbiol Lett 2003;224:277-83. [PMID: 12892893 DOI: 10.1016/S0378-1097(03)00470-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
124 Brawner KM, Yeramilli VA, Duck LW, Van Der Pol W, Smythies LE, Morrow CD, Elson CO, Martin CA. Depletion of dietary aryl hydrocarbon receptor ligands alters microbiota composition and function. Sci Rep 2019;9:14724. [PMID: 31604984 DOI: 10.1038/s41598-019-51194-w] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
125 Iankov ID, Petrov DP, Mladenov IV, Haralambieva IH, Ivanova R, R Velev V, Mitov IG. Production and characterization of monoclonal immunoglobulin A antibodies directed against Salmonella H:g,m flagellar antigen. FEMS Immunol Med Microbiol 2002;33:107-13. [PMID: 12052565 DOI: 10.1111/j.1574-695X.2002.tb00579.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
126 Mundodi V, Kucknoor AS, Chang TH, Alderete JF. A novel surface protein of Trichomonas vaginalis is regulated independently by low iron and contact with vaginal epithelial cells. BMC Microbiol 2006;6:6. [PMID: 16448556 DOI: 10.1186/1471-2180-6-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]